TipRanks
Go Ultimate55% OFF

Karl Mahler Insider Profile

4 Followers

Karl Mahler, Director at Marinomed Biotech AG, holds ― shares in Marinomed Biotech AG (Ticker: DE:93Z). Most recently, Karl Mahler Bought 1,500 shares of Marinomed Biotech AG on Mar 31, 2026 for an estimated value of €21.00K.

Karl Mahler's Trading History

93Z
Marinomed Biotech AG
Mar 31, 2026DirectorInformative Buy21.00K―
DE:93Z
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 31, 2026Informative Buy€21.00K1,500€14.00-72.80%―
Jan 20, 2025Informative Buy€21.00K1,500€14.00+27.10%―

You May Also Like

Karl Mahler insider profile FAQ

What is the percentage of profitable transactions made by Karl Mahler?
The percentage of profitable transactions made by Karl Mahler is 50%.
What is the average return per transaction made by Karl Mahler?
The average return per transaction made by Karl Mahler is -22.80%.
What stocks does Karl Mahler hold?
Karl Mahler holds: DE:93Z stocks.
What was Karl Mahler’s latest transaction?
Karl Mahler’s latest transaction was an Informative Buy of €21.00K.
What was Karl Mahler's most profitable transaction?
Karl Mahler’s most profitable transaction was an Informative Buy of DE:93Z stock on January 20, 2025. The return on the trade was 27.10%.
What is Karl Mahler's role in Marinomed Biotech AG?
Karl Mahler's role in Marinomed Biotech AG is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.